Payment & Shipping Terms:
|Appearance::||White Powder||Delivery::||By DHL, TNT, FedEx, HKEMS, UPS, Etc.|
|Molecular Formula::||C211H366N72O67S1||Molecular Weight::||5135.89|
|Grade::||Pharmaceutical Grade||Policy:||Re-sent Policy|
Alias: TH-9507, ThGRF(1-44), Hex-hGRF
Appearance: White Lyophilized Powder
Place of Origin: China
Method of Analysis: HPLC
Fat Loss and the Tesamorelin Peptide
Tesamorelin has been shown to reduce lipodystrophy in HIV-infected individuals. Lipodystrophy is a condition that causes changes in placement of body fat, including wasting and fat accumulation, and changes in metabolism. Similar to Tesamorelin is Sermorelin, which may be taken with GHRP-6 is clinical trials, that also promotes production and possible fat loss. Individuals with lipodystrophy may develop excess fat most notably around the liver, stomach, and other abdominal organs (visceral body fat).
Who should not use tesamorelin?
Given the potential for developing cancer when using tesamorelin, individuals should be screened and assessed for current or possible new cancers. People should weigh the risks and benefits before making decisions to start on the drug. Tesamorelin has not been studied in children.
Pregnant women and people with an active cancer should not use it. People going through cancer treatment should wait until their therapy has stopped and it’s clear that the cancer has become inactive before starting tesamorelin. Also, anyone with earlier head trauma, radiation of the head, or issues regarding the pituitary gland should not use the drug.
Since clinical study beyond a year has not been done, it’s unknown what long-term side effects may occur, including heart health. In people who start tesamorelin but do not show clear improvement in their deep belly fat and longer-term use may be questionable, it may be wise to stop using the drug.
|MGF||2mg/vials, 10 vials/box|
|PEG MGF||2mg/vials, 10 vials/box|
|CJC-1295 with DAC||2mg/vials, 10 vials/box|
|CJC-1295 without DAC||2mg/vials, 10 vials/box|
|PT-141||10mg/vials, 10 vials/box|
|MT-1||10mg/vials, 10 vials/box|
|MT-2||10mg/vials, 10 vials/box|
|GHRP-2||5mg/vials, 10 vials/box|
|GHRP-2||10mg/vials, 10 vials/box|
|GHRP-6||5mg/vials, 10 vials/box|
|GHRP-6||10mg/vials, 10 vials/box|
|Ipamorelin||2mg/vials, 10 vials/box|
|Hexarelin||2mg/vials, 10 vials/box|
|Sermorelin||2mg/vials, 10 vials/box|
|Oxytocin||2mg/vials, 10 vials/box|
|TB500||2mg/vials, 10 vials/box|
|pentadecapeptide BPC 157||2mg/vials, 10 vials/box|
|HGH 176-191||2mg/vials, 10 vials/box|
|Triptorelin||2mg/vials, 10 vials/box|
|Tesamorelin||2mg/vials, 10 vials/box|
|Gonadorelin||2mg/vials, 10 vials/box|
|Gonadorelin||10mg/vials, 10 vials/box|
|DSIP||2mg/vials, 10 vials/box|
|Selank||5mg/vials, 10 vials/box|
Contact Person: Gavin Lee